The Naomi Berrie Diabetes Center hosted a “Preceptorial in Diabetes”, sponsored by the Endocrine Fellows Foundation, (EFF) which offered seven fellows from around the country a front row view of the vigorous research and quality clinical programs at the Berrie Center.
“It was a full week of opportunity for the fellows to experience the richness of what we do here,” said Magdalena Bogun, MD, who lead the week along with John P. Bilezikian, MD, of the Division of Endocrinology at Columbia. “We could have used another full week and it still would have been just the tip of the iceberg.”
The EFF is a non-profit organization whose mission is to foster the advancement of fellows in endocrinology, diabetes and metabolism through mentoring, education, research, funding and career support. A preceptorial is a method of study where a small group of students meets in regular conference with faculty members.
There were faculty conferences with Berrie Center Co-Director Robin Goland, MD, J. Merrill Eastman Professor of Clinical Diabetes, who talked about the epidemiology and pathophysiology of type 1 diabetes prevention trials; Domenico Accili, MD, who spoke about the future of diabetes treatment; Geneticist Wendy Chung, MD, PhD, who talked of monogenic diabetes and stem-cell biologist Dieter Egli, PhD, who conducted a session on novel therapies in diabetes.
There was a hands-on session with Berrie Center diabetes educator Courtney Melrose, RD, CDE, MPH,on new insulin pumps, sensors and hybrid systems. The fellows also attended the weekly Tuesday lunch group on automated insulin delivery systems. Co-Director Rudy Leibel, MD, the Christopher J. Murphy Memorial Professor of Diabetes Research, spoke to the fellows about the molecular physiology of body weight regulation.
“I thoroughly enjoyed the course,” said Maha Gopalakrishnamoorthy, MD, a postdoctoral clinical fellow at Columbia University Irving Medical Center. “There were great speakers and a good balance of topics.”
All told the fellows had nearly 30 different learning sessions over five days—and on the sixth day, Saturday, it was the 21st Annual Frontiers in Diabetes Research Symposium, devoted to technical innovation for current and future care of patients with diabetes.